Intriguingly, and in contrast to effects observed in pregnant women, antenatal iron supplementation led to increased intact-FGF23 concentrations in neonates, which conversely suggests that maternal iron deficiency during pregnancy leads to decreased neonatal intact-FGF23 concentrations, without an apparent effect on neonatal serum phosphate concentration. The gene discussed is FGF23; the disease is Iron deficiency anemia.